Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added to the page footer, and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. This is a UI/metadata update and does not alter trial data or study details.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed; no study data or page content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding/operating-status banner has been removed; core trial information remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check63 days agoChange DetectedThe history shows updates to Study Status, Recruitment Status, and Contacts/Locations across multiple versions. These updates reflect changes in the trial's current state and logistical details over time.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check99 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.